
Avenues Recovery Center at Clarksville
Avenues Recovery Center at Clarksville is an addiction treatment facility at 4601 Medical Plaza Way, Clarksville, Indiana 47129, in Clark County. It reports detox, intensive outpatient (iop), outpatient, residential, telehealth to SAMHSA.
Facility details
- Phone
- (930) 203-1000
- Address
- 4601 Medical Plaza Way, Clarksville, IN 47129
- County
- Clark County
- Website
- www.avenuesrecovery.com
Level of care
Medication for addiction treatment
Licensing and accreditation
- The Joint Commission — An independent, not-for-profit group in the United States that administers voluntary accreditation programs for hospitals and other healthcare organizations.
- State substance use treatment agency — Government organization responsible for planning, organizing, delivering, and monitoring substance use disorder services in their respective state.
- State department of health
Payment accepted
Specialised programs
Ages accepted
Sex accepted
Everything Avenues Recovery Center at Clarksville reports to SAMHSA
125 service codes across 27 categories. Terms SAMHSA defines link to the glossary; the rest are federal labels SAMHSA publishes without a definition.
Age Groups Accepted
Ancillary Services
Assessment/Pre-treatment
- Comprehensive mental health assessment
- Comprehensive substance use assessment
- Complete medical history/physical exam
- Screening for mental disorders
- Screening for substance use
- Screening for tobacco use
Type of Alcohol Use Disorder Treatment
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
Detoxification (medical withdrawal) Services
- Alcohol Detoxification
- Benzodiazepines Detoxification
- Cocaine Detoxification
- Medication routinely used during detoxification
- Methamphetamines detoxification
- Opioids detoxification
Education and Counseling Services
- Family counseling
- Group counseling
- HIV or AIDS education, counseling, or support
- Health education services other than HIV/AIDS or hepatitis
- Individual counseling
- Marital/couples counseling
- Substance use disorder education
- Hepatitis education, counseling, or support
- Smoking/vaping/tobacco cessation counseling
Facility Operation (e.g., Private, Public)
Facility Vaping Policy
- Vaping permitted in designated area
License/Certification/Accreditation
- The Joint Commission
- State substance use treatment agency
- State department of health
Medical Services
- Hepatitis A (HAV) vaccination
- Hepatitis B (HBV) vaccination
Opioid Medications used in Treatment
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
External Opioid Medications Source
- In-network prescribing entity
- No formal relationship with prescribing entity
- Other contracted prescribing entity
Type of Opioid Treatment
- Buprenorphine maintenance
- Buprenorphine detoxification
- Lofexidine or Clonidine detoxification
- Accepts clients using MAT but prescribed elsewhere
- Maintenance service with medically supervised withdrawal after stabilization
- Relapse prevention with naltrexone
- Prescribes buprenorphine
- Prescribes naltrexone
Other Services
- Treatment for gambling disorder
- Treatment for other addiction disorder
Payment/Insurance/Funding Accepted
- Cash or self-payment
- Medicaid
- Private health insurance
- Federal military insurance (e.g., TRICARE)
Pharmacotherapies
- Acamprosate (Campral®)
- Buprenorphine (extended-release, injectable)
- Buprenorphine with naloxone
- Buprenorphine without naloxone
- Clonidine
- Disulfiram
- Lofexidine
- Medications for Hepatitis C treatment
- Medications for HIV treatment
- Medication for mental disorders
- Medications for pre-exposure to prophylaxis
- Nicotine replacement
- Non-nicotine smoking/tobacco cessation
- Naltrexone (oral)
- Naltrexone (extended-release, injectable)
Payment Assistance Available
Recovery Support Services
Testing
Service Setting
- Intensive outpatient treatment
- Outpatient day treatment or partial hospitalization
- Outpatient methadone/buprenorphine or naltrexone treatment
- Outpatient
- Regular outpatient treatment
- Residential detoxification
- Residential/24-hour residential
- Long-term residential
- Short-term residential
Special Programs/Groups Offered
- Clients with co-occurring pain and substance use disorders
- Clients with co-occurring mental and substance use disorders
- Adult men
- Seniors or older adults
- Clients who have experienced trauma
- Adult women
- Young adults
External Source of Medications Used for Alcohol Use Disorder Treatment
- In-network prescribing entity
- No formal relationship with prescribing entity
- Other contracted prescribing entity
Facility Smoking Policy
Treatment Approaches
Type of Care
Transitional Services
- Aftercare/continuing care
- Discharge Planning
- Naloxone and overdose education
- Outcome follow-up after discharge
Recent Google reviews
The 3 most recent reviews of Avenues Recovery Center at Clarksville published on Google, fetched 2026-08-19. They were left by Google users, not collected by this site, and are reproduced with a link to the original.
5/5an hour ago
This place saved my life period. The staff here care more then your family it seems like, Chuck, Angie, Lonnie, Gonzo, Chris, Jeff, Casey and so many I'm forgetting about "please forgive me" but if you're struggling with addiction this is the absolute perfect place to come. They truly care and I will be forever grateful.
5/52 hours ago
Thank you for saving my life and giving me the tools and resources to stay plugged in with my family of recoving addicts like . God bless this program.. Thank u so much Avenues for allowing me to come to receive my sobriety back and get true connections to stay sober..
5/52 hours ago
I had a very safe, very good experience while at Avenues ! I would highly recommend it !
Before you go: availability, cost, and accepted insurance change often. Call the facility to confirm. If something on this page is wrong, tell us and we will correct it.
Source: SAMHSA FindTreatment.gov facility listing (Indiana), parsed 2026-08-19.